A lot of good things are about to happen with our
Post# of 72446
(Total Views: 421)
Posted On: 03/26/2018 7:07:53 AM
A lot of good things are about to happen with our little IPIX. And the pace of when they start happening can progress very quickly.
FDA meeting for brilacidin, breakthrough designation and potential licensing/partnership.
Prurisol could set the stage nicely for bringing us a nice price.
And still, many just don't get it about where kevetrin is headed and what it's accomplished.
The potential is there. My money is on making it and saying good riddance to the OTC.
Good answers to the fudsters...
FDA meeting for brilacidin, breakthrough designation and potential licensing/partnership.
Prurisol could set the stage nicely for bringing us a nice price.
And still, many just don't get it about where kevetrin is headed and what it's accomplished.
The potential is there. My money is on making it and saying good riddance to the OTC.
Good answers to the fudsters...
Quote:
Due to a request from a poster, I looked at the lieHUB last 50 posts.
They are filled with desperate lies from the bashers.
It is ABSOLUTELY UNTRUE to claim that the Prurisol first clinical trial was unsuccessful. A LIE. It was quite successful even at a relatively low dose. It made perfect sense for the company to increase the dosage (two different sized doses now) in the current clinical trial.
It is ABSOLUTELY UNTRUE to claim that the management would have results now and is lying about it. That would be a violation of law and would leave them open to lawsuits. No way would they do that.
It is ABSOLUTELY UNTRUE to say that the results are "easy" to compile and
"they just have to feed it into a computer." No one with any sense thinks that's true. What do they think, it's "Lost in Space" and you put the results in Robbie the Robot's mouth, and he spits out an answer?
The Prurisol trial is very complex. About 200 patients, at multiple clinical trial sites, and a HUMAN BEING has to look at any lesions the patient may have and determine what the seriousness is. All of that is going to have to be at least double-checked. Then, we have varying doses, and placebo, and there will have to be analysis that combines looking at the severity of the initial lesions, how they look after taking Prurisol, AND -- which size dose they got.
How can anyone think that this analysis would be easy?
One of the good posters, I think it was Yooper but I could be wrong, found that other clinical trials for psoriasis took 104 days for data compilation.
Doesn't sound like they could just "feed it into a computer" to me.
By the way, it also looks like the other person who sometimes writes "TIAB's posts is in charge now. He's not as smart as the original writer. He makes it real obvious that he's in the bashing business.
(6)
(0)